blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3359174

EP3359174 - COMPOSITION CONTAINING LACTIC ACID BACTERIA AND ITS USE TO TREAT ATOPIC DERMATITIS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  04.03.2020
Database last updated on 02.11.2024
FormerRequest for examination was made
Status updated on  13.07.2018
FormerThe international publication has been made
Status updated on  18.04.2017
Most recent event   Tooltip26.10.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Galderma Research & Development
2400 Route des Colles
Les Templiers
06410 Biot / FR
[2018/33]
Inventor(s)01 / ROSIGNOLI, Carine
22 place des Arcades
06250 Mougins / FR
 [2018/33]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[N/P]
Former [2018/33]Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
Application number, filing date16778059.207.10.2016
[2018/33]
WO2016EP74065
Priority number, dateUS201562238244P07.10.2015         Original published format: US 201562238244 P
US201662340266P23.05.2016         Original published format: US 201662340266 P
[2018/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017060468
Date:13.04.2017
Language:EN
[2017/15]
Type: A1 Application with search report 
No.:EP3359174
Date:15.08.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 13.04.2017 takes the place of the publication of the European patent application.
[2018/33]
Search report(s)International search report - published on:EP13.04.2017
ClassificationIPC:A61K35/745, A61K9/00, A61K35/747, A61P17/00
[2018/33]
CPC:
A61K35/747 (EP,KR,US); A61K35/745 (EP,KR,US); A61K47/10 (EP,KR,US);
A61K47/183 (EP,US); A61K47/44 (EP,KR,US); A61K9/0014 (EP,KR,US);
A61K9/06 (EP,KR,US); A61K9/08 (EP,KR,US); A61P17/00 (KR);
A61P17/04 (EP,US); A61K2035/115 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/33]
TitleGerman:ZUSAMMENSETZUNG MIT MILCHSÄUREBAKTERIEN UND DEREN VERWENDUNG ZUR BEHANDLUNG VON ATOPISCHER DERMATITIS[2018/33]
English:COMPOSITION CONTAINING LACTIC ACID BACTERIA AND ITS USE TO TREAT ATOPIC DERMATITIS[2018/33]
French:COMPOSITION CONTENANT DES BACTÉRIES D'ACIDE LACTIQUE ET SON UTILISATION POUR TRAITER LA DERMATITE ATOPIQUE[2018/33]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase03.05.2018National basic fee paid 
03.05.2018Designation fee(s) paid 
03.05.2018Examination fee paid 
Examination procedure03.05.2018Examination requested  [2018/33]
03.05.2018Date on which the examining division has become responsible
05.11.2018Amendment by applicant (claims and/or description)
09.03.2020Despatch of a communication from the examining division (Time limit: M06)
09.09.2020Reply to a communication from the examining division
07.06.2021Despatch of a communication from the examining division (Time limit: M04)
14.10.2021Reply to a communication from the examining division
Fees paidRenewal fee
11.10.2018Renewal fee patent year 03
15.10.2019Renewal fee patent year 04
14.10.2020Renewal fee patent year 05
29.09.2021Renewal fee patent year 06
25.10.2022Renewal fee patent year 07
25.10.2023Renewal fee patent year 08
25.10.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO03070203  (NESTLE SA [CH], et al) [X] 1,3,4,9* claim - *;
 [XI]US2006171936  (GUENICHE AUDREY [FR], et al) [X] 1-4,9-14 * paragraph [0010] * * paragraph [0013] * * paragraph [0015] * * paragraph [0032] - paragraph [0033] * * paragraph [0036] - paragraph [0042] * * paragraph [0057] * * paragraph [0085] * * paragraph [0095] * * claim - * [I] 1-14;
 [XI]EP1736537  (ORGANOBALANCE GMBH [DE]) [X] 1-3,7-14 * paragraph [0021] * * paragraph [0028] * * paragraph [0031] * * paragraph [0036] - paragraph [0037] * * paragraph [0040] - paragraph [0041] * * paragraph [0049] - paragraph [0055] * * claim - * [I] 1-14;
 [XDI]WO2010130662  (NESTEC SA [CH], et al) [XD] 1-6,9,12,14 * page 1, line 3 - line 10 * * page 5, line 7 - line 23 * * page 13, line 18 - page 14, line 31 * * claim - * [I] 1-14;
 [X]EP2397145  (NESTEC SA [CH]) [X] 1-6,9,12-14 * paragraph [0001] * * paragraph [0015] - paragraph [0017] * * paragraph [0022] - paragraph [0023] * * paragraph [0037] - paragraph [0038] * * paragraph [0044] - paragraph [0045] * * claim - *;
 [X]WO2012071654  (BIO K PLUS INTERNAT INC [CA], et al) [X] 1-3,9-11,14 * page 4, line 12 - page 5, line 24 * * page 6, line 25 - page 7, line 28 * * page 12, line 6 - line 13 * * claim - *;
 [X]US2014079677  (BAUR MARKUS [CH], et al) [X] 1-14 * paragraph [0011] - paragraph [0015] * * paragraph [0040] - paragraph [0041] * * paragraph [0050] * * paragraph [0052] - paragraph [0062] * * examples 5-10 * * claim - *;
 [X]EP2796142  (KIM DAE HYUN [KR]) [X] 1-3,5,6,9,14 * paragraph [0024] * * paragraph [0028] * * paragraph [0126] * * claim - *;
 [X]  - TANAKA AKANE ET AL, "Prophylactic effect of oral administration of Lactobacillus johnsonii NCC533 (La1) during the weaning period on atopic dermatitis in NC/NgaTnd mice", EUROPEAN JOURNAL OF DERMATOLOGY,, (20080301), vol. 18, no. 2, ISSN 1167-1122, pages 136 - 140, XP009185116 [X] 1-4,9,14 * abstract * * page 137, column l, paragraph Bacteria preparation * * page 139, column r, paragraph Conclusion *
 [X]  - INOUE R ET AL, "Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga", BRITISH JOURNAL OF DERMATOLOGY, OXFORD : WILEY-BLACKWELL, UK, (20070301), vol. 156, no. 3, doi:10.1111/J.1365-2133.2006.07695.X, ISSN 0007-0963, pages 499 - 509, XP002521659 [X] 1-4,9,14 * abstract * * page 500, column l, paragraph last full paragraph - column r, paragraph preparation of lactobacillus * * page 508, column l, paragraph last full paragraph *

DOI:   http://dx.doi.org/10.1111/J.1365-2133.2006.07695.X
by applicantWO2010130662
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.